Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad K Porter

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Msphere|September 24, 2020
Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53GRobert W Frenck, Michelle Dickey, Akamol E Suvarnapunya, et al.
Microorganisms|October 28, 2023
Efficacy of an Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccine on the Incidence and Severity of Traveler's Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity ScoreNicole Maier, Shannon L Grahek, Jane Halpern, et al.
Plos One|March 4, 2016
An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coliChad K Porter, Mark S Riddle, Ashley N Alcala, et al.
Infection and Immunity|December 20, 2012
The polysaccharide capsule of Campylobacter jejuni modulates the host immune responseAlexander C Maue, Krystle L Mohawk, David K Giles, et al.
Microorganisms|April 27, 2024
Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic <i>E. coli</i> Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701)Kawsar R Talaat, Chad K Porter, Subhra Chakraborty, et al.
Vaccine|August 22, 2021
Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coliTida Lee, Ramiro L Gutiérrez, Milton Maciel, et al.
The Journal of Infectious Diseases|March 22, 2019
Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection ModelStephen J Savarino, Robin McKenzie, David R Tribble, et al.
Msphere|September 24, 2020
Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53GKristen A Clarkson, Robert W Frenck, Michelle Dickey, et al.
Frontiers in Cellular and Infection Microbiology|September 17, 2021
Exploring Changes in the Host Gut Microbiota During a Controlled Human Infection Model for <i>Campylobacter jejuni</i>Blake W Stamps, Janelle Kuroiwa, Sandra D Isidean, et al.
Vaccine|May 9, 2021
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global accessIbrahim Khalil, Richard Walker, Chad K Porter, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Msphere|September 24, 2020
Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53GRobert W Frenck, Michelle Dickey, Akamol E Suvarnapunya, et al.
Microorganisms|October 28, 2023
Efficacy of an Enterotoxigenic <i>Escherichia coli</i> (ETEC) Vaccine on the Incidence and Severity of Traveler's Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity ScoreNicole Maier, Shannon L Grahek, Jane Halpern, et al.
Plos One|March 4, 2016
An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coliChad K Porter, Mark S Riddle, Ashley N Alcala, et al.
Infection and Immunity|December 20, 2012
The polysaccharide capsule of Campylobacter jejuni modulates the host immune responseAlexander C Maue, Krystle L Mohawk, David K Giles, et al.
Microorganisms|April 27, 2024
Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic <i>E. coli</i> Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701)Kawsar R Talaat, Chad K Porter, Subhra Chakraborty, et al.
Vaccine|August 22, 2021
Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coliTida Lee, Ramiro L Gutiérrez, Milton Maciel, et al.
The Journal of Infectious Diseases|March 22, 2019
Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection ModelStephen J Savarino, Robin McKenzie, David R Tribble, et al.
Msphere|September 24, 2020
Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53GKristen A Clarkson, Robert W Frenck, Michelle Dickey, et al.
Frontiers in Cellular and Infection Microbiology|September 17, 2021
Exploring Changes in the Host Gut Microbiota During a Controlled Human Infection Model for <i>Campylobacter jejuni</i>Blake W Stamps, Janelle Kuroiwa, Sandra D Isidean, et al.
Vaccine|May 9, 2021
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global accessIbrahim Khalil, Richard Walker, Chad K Porter, et al.
Pageof 13